GOVITAL CHONDROFLEX
Food supplement declared in France, declaration No 2019-1-581
GOVITAL CHONDROFLEX is a food supplement declared in France. Status: retiré du marché le 3 May 2023. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRES URGO HEALTHCARE
- Status
- Retiré du marché le 3 May 2023
- Form
- Comprimé
- Daily dose
- 2 cp/j
- Directions for use
- 2 comprimés à avaler avec un grand verre d’eau de préférence le matin au cours du petit-déjeuner
- Intended populations
- Personnes de plus de 60 ans, Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Articulations
Declaration 151514, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 3 May 2023, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Glucosamine sulfate 2 KCl | not declared |
| Sulfate de chondroïtine | not declared |
| Méthylsulfonate de méthane | not declared |
| Collagène hydrolysé | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
Additives
E464, E470b, E172, E120, E460, E170, E1521
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Une augmentation de l’effet des anticoagulants coumariniques a été observée au cours d’un traitement concomitant à la prise de glucosamine. Les personnes exposées à ces associations doivent être surveillées avec une attention toute particulière au début et à la fin de la prise de glucosamine. Ne pas consommer en cas d'allergie aux crustacés.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.